Preformulation of curcumin and eugenol nanoemulsion in-situ mucoadhesive gel

In situ mucoadhesive gel provides the drug release at a controlled rate for prolong period of time directly to the target site which reduces side effects, thus improving patient compliance. The main advantages of the implants of formation in situ are as follows: they can easily be injected into periodontal pockets, harden to form a solid implant with customized geometry, the time-controlled release of drugs and no need to remove the empty remnants. For the formulation of Curcumin and Eugenol Nanoemulsion in-situ Mucoadhesive gel poloxamer-407 was used as thermo reversible agent and surfactant for nanoemulsion while carbopol-934 was used as mucoadhesive and pH sensitive agent. Curcumin and Eugenol Nanoemulsion in-situ Mucoadhesive gel were prepared and evaluated for zeta potential, globule size, size distribution, viscosity, syringeability, gelation temperature, mucoadhesive strength, in-vitro release study. Batch F3 showed good in vitro drug release and also shown good result for all parameters when compared with all other formulations. Hence, Batch F3 was considered as the optimized formulations. Batch F3 was subjected for four different models viz. Zero order, First order, Higuchi matrix and Peppas model equations and the formulations best fit in to the Peppas model by giving the value of diffusion exponent (n) 1.596 for curcumin and 1.592 for Eugenol respectively, that indicate the formulation had release the drug by case II transport.